About 6 months ago I had the opportunity to speak with Rosetta and some of the genomic testing they are doing, pretty amazing stuff especially imagewith the test of being able to detect cancer of the unknown with lung tumors.  This will bring a great treatment opportunity to many as sometimes cancer moves to the lungs from other parts of the body, which means the drugs used to fight the tumor could be different than those used for lung cancer.  They also have a similar process in place for colon cancer.  The lab tests are around 3k if I remember properly and are done here in the US.  BD

NEW YORK (GenomeWeb News) – MicroRNA diagnostics company Rosetta Genomics said today that it has received Clinical Laboratory Improvement Amendments certification in three states.

The Rehovot, Israel-based company said that it has passed the survey for CLIA certification in California, Rhode Island, and Maryland to conduct molecular diagnostic tests at its Rosetta Laboratories, bringing the total number of states from which it has received CLIA certification to 48.

Rosetta Genomics Gains CLIA Certification in Three More States | GenomeWeb Daily News | DxPGx | GenomeWeb

Related Reading:

Rosetta Genomics Publishes Data on Lung Cancer Test – Journal of Clinical Oncology

Rosetta Genomics Interview – microRNA for Diagnosing Lung Cancer Tumors
Teva to Distribute Three Rosetta Genomics Cancer Diagnosis Tests in Israel and Turkey

Rosetta Genomics Unveils Colon Cancer Screening Diagnostic using MicroRNA Biomarkers


Post a Comment

Google Analytics Alternative